Marios Dimitriou
Affiliated to Research
E-mail: marios.dimitriou@ki.se
Visiting address: NEO Medicinaren 25, HERM plan 7, Hälsovägen 7C (lastkaj), 14157 Huddinge/Stockholm
Postal address: H7 Medicin, Huddinge, H7 Hematologi Hellström Lindberg, 171 77 Stockholm
About me
- I received my B.Sc. degree in Molecular Biology and Genetics from Dimokritus
University of Thrace (Greece - 2005). I subsequently received a Ph.D. in
Medical Sciences from B.S.R.C Alexander Fleming (Greece - 2009) with special
focus on post-transcriptional modifications and their role in hematopoietic
development and colon cancer. In 2010 I had 1 year interruption in research
due to my compulsory military service where I specialized as Microbiologist
Assistant in the microbiology laboratory of Military Hospital for Special
Diseases (414 - Athens, Greece). I then joined the group of Professor Eva
Hellström-Lindberg and Professor Sten-Eirik Jacobsen at Karoliska Institute
(Sweden – 2011) as post-doctorate researcher to focus my research on the
hematopoietic and MDS (myelodysplastic syndromes) cancer stem cells. From
October 2017, I am an Assistant Professor and research associate for
Professor Eva Hellström-Lindberg at Center for Regenerative Medicine and
Hematology (HERM), Department of Medicine Huddinge, Karolinska Institutet.
Overall, I am specialized in molecular biology, RNA and
post-transcriptional field, in HSC and leukemic/cancer stem cell biology,
various molecular biology/genetics and sequencing platforms as well as
multi-color flow cytometry sorting.
2018, Research Grant awarded from Åke Olsson Foundation for Hematological
Research (Sweden)
2021, Research Grant awarded from Center of Innovative Medicine CIMED,
Karolinska (Sweden)
2005, B.Sc. in Molecular Biology and Genetics, Democritus University of
Thrace, Alexandroupoli, Greece
2009, Ph.D. in Medicine at University of Ioannina and Biomedical Sciences
Research Center Alexander Fleming, Greece
2011-2017, Postdoctoral researcher, HERM, Department of Medicine Huddinge,
Karolinska Institutet, Sweden
Research
- My research focus is on malignant hematopoietic stem cell (HSC) functions and
MDS stem cells. The overreaching aim is to characterize the cellular and
molecular heterogeneity but also the RNA usage within MDS stem cells. The
vision is to explore novel solutions and tools to treat the disease in its
origin by understanding and manipulating the RNA dynamics of MDS stem cells.
Articles
- Article: EBIOMEDICINE. 2024;105:105168
- Article: NATURE COMMUNICATIONS. 2024;15(1):3621
- Article: JOURNAL OF CLINICAL ONCOLOGY. 2024;42(12):1378-1390
- Article: BLOOD. 2024;143(11):953-966
- Article: CANCER RESEARCH. 2024;84(2):211-225
- Article: NATURE COMMUNICATIONS. 2023;14(1):7680
- Article: CLINICAL CANCER RESEARCH. 2023;29(20):4256-4267
- Article: MOLECULAR CELL. 2023;83(7):1165-1179.e11
- Article: NATURE CELL BIOLOGY. 2022;24(3):299-306
- Article: LEUKEMIA. 2021;35(8):2371-2381
- Article: LEUKEMIA. 2020;34(1):271-282
- Article: PLOS PATHOGENS. 2020;16(1):e1008264
- Article: CELL. 2018;173(5):1204-1216.e26
- Article: BLOOD ADVANCES. 2018;2(5):534-548
- Article: BLOOD. 2017;130(7):881-890
- Article: HAEMATOLOGICA. 2017;102(3):498-508
- Article: ONCOTARGET. 2016;7(45):72685-72698
- Article: ONCOTARGET. 2016;7(16):22103-22115
- Article: BRITISH JOURNAL OF HAEMATOLOGY. 2015;171(4):478-490
- Article: JOURNAL OF CLINICAL INVESTIGATION. 2012;122(1):48-61
All other publications
- Letter: BLOOD ADVANCES. 2022;6(16):4705-4709
- Letter: HAEMATOLOGICA. 2015;100(6):e223-e225
- Review: ERNST SCHERING RESEARCH FOUNDATION WORKSHOP. 2006;(4):37-57